Assessment of a modified Child-Pugh-Turcotte score to predict early mortality after liver transplantation

Transplant Proc. 2009 Oct;41(8):3114-6. doi: 10.1016/j.transproceed.2009.07.098.

Abstract

Objective: The Model for End-Stage Liver Disease (MELD) predicts mortality on the transplant list; however, it has not been of much use to predict posttransplant outcomes. Several prognostic models have been tested among patients with cirrhosis; nevertheless, their predictive value has not been established in the posttransplant setting. We recently modified the Child-Pugh-Turcotte (CPT) score by adding creatinine levels (CPT + Cr), which has proven useful for patients with alcoholic cirrhosis. This retrospective analysis sought to predict early (1 month) mortality using CPT + Cr versus 5 other prognostic models in patients who underwent orthotopic liver transplantation (OLT) at our center.

Materials and methods: We included 48 consecutive patients (30 males, 18 females, median age 51 years). The predictive values of CPT + Cr were compared with CPT scores without or with the Huo modification, CPT + Na, MELD, and MESO, which is the MELD to serum Na ratio. Pearson correlations and ROC curves as evidenced by the area under the curve (AUC) were determined for each index. P < .05 was considered to be significant.

Results: CPT + Cr showed the highest correlation with the risk of death (r = .368, P = .01); MELD and MESO were the lowest (r = .204, P = NS; and r = .254, P = NS, respectively). ROC analysis showed the best predictive value of CPT and CPT-Crea with AUC of 0.758 (P = .010) and 0.748 (P = .011) respectively, as compared to 0.689 for MESO and 0.659 for MELD (both NS).

Conclusions: A modified CPT score with creatinine levels may be of value to predict early death after OLT. Its usefulness must be validated in a prospective study of a large patient cohort.

MeSH terms

  • Adult
  • Bilirubin / blood
  • Creatinine / blood
  • Female
  • Hepatic Encephalopathy / mortality
  • Humans
  • Kidney Diseases / complications
  • Kidney Diseases / mortality
  • Liver Cirrhosis / blood
  • Liver Cirrhosis / mortality
  • Liver Cirrhosis / surgery
  • Liver Failure / blood
  • Liver Failure / mortality
  • Liver Failure / surgery
  • Liver Transplantation / mortality*
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Risk Factors
  • Survival Analysis
  • Survivors

Substances

  • Creatinine
  • Bilirubin